ATE166464T1 - Verfahren und zusammensetzungen zur erhöhung des bild-kontrastes - Google Patents

Verfahren und zusammensetzungen zur erhöhung des bild-kontrastes

Info

Publication number
ATE166464T1
ATE166464T1 AT94920543T AT94920543T ATE166464T1 AT E166464 T1 ATE166464 T1 AT E166464T1 AT 94920543 T AT94920543 T AT 94920543T AT 94920543 T AT94920543 T AT 94920543T AT E166464 T1 ATE166464 T1 AT E166464T1
Authority
AT
Austria
Prior art keywords
image contrast
compositions
increase image
human
relates
Prior art date
Application number
AT94920543T
Other languages
English (en)
Inventor
Anders Ericcson
Anne Kjersti Fahlvik
Anders Hemmingsson
Mats Wikstrom
Audun Oksendal
Tore Bach-Gansmo
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Application granted granted Critical
Publication of ATE166464T1 publication Critical patent/ATE166464T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Signal Processing (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Semiconductor Lasers (AREA)
AT94920543T 1993-07-12 1994-07-11 Verfahren und zusammensetzungen zur erhöhung des bild-kontrastes ATE166464T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314499A GB9314499D0 (en) 1993-07-12 1993-07-12 Method

Publications (1)

Publication Number Publication Date
ATE166464T1 true ATE166464T1 (de) 1998-06-15

Family

ID=10738767

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94920543T ATE166464T1 (de) 1993-07-12 1994-07-11 Verfahren und zusammensetzungen zur erhöhung des bild-kontrastes

Country Status (14)

Country Link
US (2) US5869023A (de)
EP (1) EP0708927B1 (de)
JP (1) JPH09502426A (de)
CN (1) CN1127040A (de)
AT (1) ATE166464T1 (de)
AU (1) AU7129594A (de)
CA (1) CA2165086A1 (de)
DE (1) DE69410466T2 (de)
ES (1) ES2116600T3 (de)
GB (1) GB9314499D0 (de)
NO (1) NO960120L (de)
NZ (1) NZ268397A (de)
WO (1) WO1995002831A1 (de)
ZA (1) ZA945038B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011922A2 (en) * 1996-02-16 1998-03-26 Nycomed Imaging As Method
GB9619758D0 (en) * 1996-09-23 1996-11-06 Nycomed Imaging As Method
DE19719033C1 (de) * 1997-04-29 1999-01-28 Schering Ag Ionenpaare, Verfahren zu ihrer Herstellung und ihre Verwendung als Kontrastmittel
GB9809776D0 (en) * 1998-05-07 1998-07-08 Nycomed Imaging As Method
SE9803718D0 (sv) 1998-05-26 1998-10-28 Klaus Potthoff Diagnostiseringsmedel
WO2000009170A1 (en) * 1998-08-10 2000-02-24 Bracco Research S.A. Combination of a positive mri contrast agent with a negative mri contrast agent
AU6386000A (en) * 1999-07-29 2001-02-19 Epix Pharmaceuticals, Inc. Targeting multimeric imaging agents through multilocus binding
US6804546B1 (en) * 2001-04-20 2004-10-12 Koninklijke Philips Electronics, N.V. Multiple contrast echo-planar imaging for contrast-enhanced imaging
US6723052B2 (en) * 2001-06-07 2004-04-20 Stanley L. Mills Echogenic medical device
TWI221406B (en) 2001-07-30 2004-10-01 Epix Medical Inc Systems and methods for targeted magnetic resonance imaging of the vascular system
NO20020780D0 (no) * 2002-02-15 2002-02-15 Amersham Health As Bildeanalyse
US8357351B2 (en) * 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
US7713517B2 (en) * 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
WO2005106519A1 (en) * 2004-05-03 2005-11-10 Koninklijke Philips Electronics N.V. System and method for magnetic resonance imaging
US7632924B2 (en) 2004-06-18 2009-12-15 Ambrx, Inc. Antigen-binding polypeptides and their uses
US20060020152A1 (en) * 2004-07-22 2006-01-26 Theobald Eugene H Method for the low temperature selective oxidation of hydrogen contained in a hydrocarbon stream
NO20043746L (no) * 2004-09-07 2006-03-08 Heidi Brurok MRI-metode for a vurdere myokardisk funksjon, levedyktighet og perfusjon i ischemisk hjertesykdom
US7854705B2 (en) * 2004-12-16 2010-12-21 Olga Pawluczyk Ex vivo verification of biopsy tissue samples
JP2008541918A (ja) * 2005-06-01 2008-11-27 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Ｍｒ分子イメージングによる造影剤の分布情報の決定
US20100129292A1 (en) 2007-04-11 2010-05-27 Oregon Health & Science University Method and apparatus for noninvasive quantitative detection of fibrosis in the heart
EP2348052A3 (de) 2007-09-17 2011-10-26 The Regents of The University of California Auf Prostatazellen in situ abzielende internalisierende humane monoklonale Antikörper
WO2009073236A1 (en) * 2007-12-05 2009-06-11 Marval Biosciences, Inc. Nano-scale contrast agents and methods of use
US20090311191A1 (en) * 2008-06-13 2009-12-17 Ananth Annapragada Imaging of atherosclerotic plaques using liposomal imaging agents
WO2010037233A1 (en) * 2008-10-02 2010-04-08 The University Of Western Ontario System and method for processing images
AU2012229156A1 (en) 2011-03-11 2013-10-31 Board Of Regents Of The University Of Nebraska Biomarker for coronary artery disease
PT3383920T (pt) 2015-11-30 2024-04-15 Univ California Entrega de carga útil específica para tumores e ativação imune utilizando um anticorpo humano que tem como alvo um antigénio altamente específico da superfície das células tumorais
WO2018089829A1 (en) 2016-11-10 2018-05-17 Fortis Therapeutics, Inc. Cd46-specific effector cells and uses thereof
US11504546B2 (en) 2019-02-28 2022-11-22 Cowles Ventures, Llc Needle guidance device for brachytherapy and method of use
US11524176B2 (en) 2019-03-14 2022-12-13 Cowles Ventures, Llc Locator for placement of fiducial support device method
CN116419747B (zh) 2020-08-07 2025-10-17 福蒂斯治疗公司 靶向cd46的免疫偶联物及其使用方法
US11630219B2 (en) * 2021-07-29 2023-04-18 Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C Pressure-regulating large-area windowless airflow proportional counter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4972837A (en) * 1983-04-26 1990-11-27 Regents Of The University Of California Contrast agents for nuclear magnetic resonance imaging
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
GB8808305D0 (en) * 1988-04-08 1988-05-11 Nycomed As Compositions
US5190744A (en) * 1990-03-09 1993-03-02 Salutar Methods for detecting blood perfusion variations by magnetic resonance imaging
IT1246380B (it) * 1990-04-12 1994-11-18 Bracco Spa Sali insolubili di lantanidi per la visualizzazione in risonanza magnetica nucleare del tratto gastro-intestinale
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region

Also Published As

Publication number Publication date
EP0708927B1 (de) 1998-05-20
DE69410466D1 (de) 1998-06-25
CN1127040A (zh) 1996-07-17
NO960120L (no) 1996-03-11
WO1995002831A1 (en) 1995-01-26
NO960120D0 (no) 1996-01-11
US5869023A (en) 1999-02-09
ES2116600T3 (es) 1998-07-16
DE69410466T2 (de) 1999-02-18
EP0708927A1 (de) 1996-05-01
NZ268397A (en) 1997-11-24
CA2165086A1 (en) 1995-01-26
ZA945038B (en) 1995-03-27
GB9314499D0 (en) 1993-08-25
JPH09502426A (ja) 1997-03-11
AU7129594A (en) 1995-02-13
US6045775A (en) 2000-04-04

Similar Documents

Publication Publication Date Title
ATE166464T1 (de) Verfahren und zusammensetzungen zur erhöhung des bild-kontrastes
DE69634035D1 (de) System zur bilderzeugung durch magnetische resonanz und katheter für eingriffsverfahren
FI962557A7 (fi) PLA2-inhibiittoreiden käyttö Alzheimerin taudin hoidossa
NO984543D0 (no) Bioaktiverte diagnostiske imaging kontrastmidler
AU3479095A (en) Heterocyclic methyl free radicals as image enhancing agents
ATE319825T1 (de) Verfahren und zusammensetzungen zur immunomodulation
DK0535091T3 (da) Knogleinducerende farmaceutiske formuleringer
BG104562A (en) Composition and method for prevention and treatment of amyloidogenic disease
IT1256248B (it) Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
NO991688L (no) Administrerbare sammensetninger og fremgangsmÕter til magnetisk resonansavbildning
DE69214229D1 (de) Verfahren und Vorrichtung zur Kontrastverbesserung von Bildern
TR199902937T2 (xx) �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe eden bile�ikler ve y�ntemler.
IL105216A0 (en) Method and kit for the diagnosis of alzheimer's disease
EP1129217A4 (de) Zusammensetzungen und verfahren zur krankheitsdiagnose und therapie
IL113897A0 (en) Emulsions of paramagnetic contrast agents for mri
GEP20053423B (en) Method of Inhibiting Amyloid Protein Aggregation and Method for Imaging of Amyloid Deposits
DE69530570D1 (de) Verfahren zur behandlung von stoehrungen des menschlichen oder tierischen koerpers durch verabreichung von aminosaeuren
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
EP1109929A4 (de) Verfahren zur diagnose von magensalz-schwundsyndrom und alzheimerscher krankheit und behandlungsverfahren
ATE251886T1 (de) Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit
NO984555L (no) T1- Lever
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
DE59107447D1 (de) Verfahren zur Bildverbesserung und Anordnung zur Durchführung des Verfahrens
DE50010234D1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
DE69430758D1 (de) Paramagnetische diagnostische zusammensetzungen und verfahren zur verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties